Illumina, Inc. Launches cBot, a Breakthrough Workflow Automation System for Next Generation Sequencing

HONOLULU--(BUSINESS WIRE)--At the 59th annual meeting of the American Society of Human Genetics, Illumina, Inc. (NASDAQ:ILMN) announced the launch and immediate availability of cBot, a new standard for ease-of-use and sequencing workflow automation. cBot is a revolutionary plug-and-play, user installable system for clonal amplification of sequencing libraries. Its automated design eliminates user intervention and enables clonal amplification to be performed in four hours with less than ten minutes of hands-on time. cBot innovations include ready-to-use, pre-packaged reagents, simple touch-screen operation, and browser-based remote monitoring. High quality results are assured by smart sensors that monitor instrument performance, combined with new chemistry and protocols that deliver higher density clusters and improved sequencing accuracy.